General Information of Disease (ID: DISH0ECJ)

Disease Name Disorder of orbital region
Synonyms
ophthalmological disorder; eye and adnexa disease; orbital region disease or disorder; orbital region disease; disorder of orbital region; disorder of eye region; disease or disorder of orbital region; disease of orbital region
Definition A disease that involves the orbital region.
Disease Hierarchy
DISH7H5I: Human disease
DISH0ECJ: Disorder of orbital region
Disease Identifiers
MONDO ID
MONDO_0002022
MESH ID
D005128
UMLS CUI
C0015397
MedGen ID
5092
SNOMED CT ID
371405004

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 7 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Betamethasone DMAHJEF Approved Small molecular drug [1]
Cortisone Acetate DMG8K57 Approved Small molecular drug [2]
Dexamethasone DMMWZET Approved Small molecular drug [3]
Hydrocortisone DMGEMB7 Approved Small molecular drug [4]
Methylprednisolone DM4BDON Approved Small molecular drug [5]
Prednisolone DMQ8FR2 Approved Small molecular drug [6]
Triamcinolone DM98IXF Approved Small molecular drug [7]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Drug(s)

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 30 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
ABCA4 TTLB52K Limited Biomarker [8]
BMP4 TTD3BSX Limited Genetic Variation [9]
CACNA1F TTJ0SO4 Limited Genetic Variation [10]
CHIA TTJB1O0 Limited Biomarker [11]
CNGA3 TTW0QOV Limited Genetic Variation [12]
GJA8 TTJ7ATH Limited Genetic Variation [13]
GUCY2D TTWNFC2 Limited Genetic Variation [14]
RPE65 TTBOH16 Limited Genetic Variation [15]
RPGR TTHBDA9 Limited Biomarker [16]
SOX2 TTCNOT6 Limited Biomarker [17]
TYR TTULVH8 Limited Biomarker [18]
TYRP1 TTFRV98 Limited Biomarker [19]
AKR1B1 TTFBNVI Strong Biomarker [20]
CA4 TTZHA0O Strong Biomarker [21]
CEP290 TT3XBOV Strong Biomarker [22]
CFH TTUW6OP Strong Genetic Variation [23]
CHM TTOA18V Strong Genetic Variation [24]
CRYAA TT8CWJG Strong Genetic Variation [25]
CTLA4 TTI2S1D Strong Biomarker [26]
DLG4 TT9PB26 Strong Biomarker [27]
GRIK5 TTO6LI7 Strong Biomarker [28]
HCAR1 TTVK4ZO Strong Biomarker [29]
LRP5 TT7VMG4 Strong Biomarker [30]
OAT TTTSCQ2 Strong Genetic Variation [31]
PRG4 TTSKF4V Strong Biomarker [32]
SCD TT6RIOV Strong Genetic Variation [33]
SRPK1 TTU3WV6 Strong Biomarker [34]
TTR TTPOYU7 Strong Genetic Variation [35]
ADAM9 TTTYQNS Definitive Biomarker [36]
POMC TT21AKM Definitive Biomarker [37]
------------------------------------------------------------------------------------
⏷ Show the Full List of 30 DTT(s)
This Disease Is Related to 3 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
RDH5 DESI4OK Limited Genetic Variation [38]
CYP2C18 DEZMWRE moderate Altered Expression [39]
SRD5A3 DEZGVDW Strong Genetic Variation [40]
------------------------------------------------------------------------------------
This Disease Is Related to 65 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
CERKL OTG4YGBR Limited Genetic Variation [41]
CRB1 OTXYUNG0 Limited Biomarker [42]
CRX OTH435SV Limited Genetic Variation [43]
GPR143 OTWUA2AV Limited Biomarker [44]
KCNV2 OTLS8OU5 Limited Biomarker [45]
MYOC OT6DAHNF Limited Genetic Variation [46]
NYX OTAGXLYP Limited Genetic Variation [47]
PDE6B OTOJMB1V Limited Biomarker [48]
PLXNA2 OTNNBJMQ Limited Biomarker [49]
RIMS1 OT10T7CK Limited Biomarker [50]
STRA6 OT2IDF27 Limited Genetic Variation [51]
CAPN5 OTQ8QM7K moderate Biomarker [52]
GUCA1B OT85S0J3 moderate Biomarker [53]
ADAMTS18 OTRMFI04 Strong Genetic Variation [54]
AIPL1 OT4VBD78 Strong Biomarker [55]
BEST1 OTWHE1ZC Strong Genetic Variation [56]
CASQ2 OT09MNQ8 Strong Altered Expression [57]
CDS1 OT2F591M Strong Biomarker [58]
CDS2 OTKC393S Strong Biomarker [58]
CNNM4 OTUXJRM1 Strong Biomarker [59]
CPSF1 OTAU1KOM Strong Genetic Variation [60]
CRB2 OTG0L2CE Strong Biomarker [42]
CRYBA1 OT8617WJ Strong Genetic Variation [61]
CTNNBL1 OT6KLHPA Strong Biomarker [62]
DGKG OTBL32T3 Strong Biomarker [63]
EFS OT06O7XL Strong Genetic Variation [64]
EPRS1 OTXK0FLB Strong Biomarker [65]
FOXD3 OTXYV6GO Strong Altered Expression [66]
FREM2 OTEK6BZR Strong Biomarker [67]
GNB5 OT3ZSAXH Strong Genetic Variation [68]
GRIP1 OT958HK1 Strong Biomarker [69]
HLA-DRA OT7KZMP2 Strong Biomarker [70]
HM13 OTGEO1LP Strong Biomarker [71]
IFNL2 OT4BMJF7 Strong Biomarker [72]
MAGEE1 OTOQQO2X Strong Biomarker [29]
MAK OTEU2G41 Strong Biomarker [73]
MFRP OTHY9ZA5 Strong Biomarker [45]
MFSD8 OT455EIC Strong Biomarker [74]
MKS1 OT83W5PB Strong Biomarker [75]
NDEL1 OTAGFML5 Strong Biomarker [76]
NDP OTGDJ4US Strong Biomarker [77]
OLFM1 OTOYPEWW Strong Biomarker [78]
OPTN OT2UXWH9 Strong Genetic Variation [79]
OTX2 OTTV05B1 Strong Biomarker [80]
PAX6 OTOC9876 Strong Biomarker [81]
PTPN12 OT5WA666 Strong Biomarker [82]
RPE OT0XT3JU Strong Biomarker [83]
RPGRIP1L OT6Z069I Strong Biomarker [84]
SEMA4A OT8901H3 Strong Genetic Variation [85]
SMIM10L2B OT04IG2N Strong Biomarker [86]
SOSTDC1 OTAKDNSM Strong Biomarker [87]
TAMM41 OTXBJ9W5 Strong Genetic Variation [58]
TMOD3 OTQPNSTH Strong Biomarker [88]
TNNT3 OT4C498E Strong Biomarker [89]
ADAMTS17 OTCFITM9 Definitive Genetic Variation [90]
ARL6 OTLV3SBS Definitive Biomarker [91]
B3GLCT OTXH6KOQ Definitive Biomarker [92]
COL2A1 OT5E59C8 Definitive Biomarker [93]
FZD4 OTGLZIE0 Definitive Biomarker [94]
OLFM2 OT7TSF7I Definitive Genetic Variation [95]
PDE6H OTMLRB1D Definitive Biomarker [96]
PITX3 OTE2KT8P Definitive Biomarker [97]
RDH12 OTELFRRJ Definitive Biomarker [98]
RP1 OTDDT69Y Definitive Biomarker [99]
RP2 OTK050I3 Definitive Biomarker [100]
------------------------------------------------------------------------------------
⏷ Show the Full List of 65 DOT(s)

References

1 Betamethasone FDA Label
2 Cortisone acetate FDA Label
3 Dexamethasone FDA Label
4 Hydrocortisone FDA Label
5 Methylprednisolone FDA Label
6 Prednisolone FDA Label
7 Triamcinolone FDA Label
8 Rescuing Trafficking Mutants of the ATP-binding Cassette Protein, ABCA4, with Small Molecule Correctors as a Treatment for Stargardt Eye Disease.J Biol Chem. 2015 Aug 7;290(32):19743-55. doi: 10.1074/jbc.M115.647685. Epub 2015 Jun 19.
9 BMP4 loss-of-function mutations in developmental eye disorders including SHORT syndrome. Hum Genet. 2011 Oct;130(4):495-504. doi: 10.1007/s00439-011-0968-y. Epub 2011 Feb 22.
10 Mosaic synaptopathy and functional defects in Cav1.4 heterozygous mice and human carriers of CSNB2.Hum Mol Genet. 2014 Mar 15;23(6):1538-50. doi: 10.1093/hmg/ddt541. Epub 2013 Oct 26.
11 Chitinase levels in the tears of subjects with ocular allergies.Cornea. 2008 Feb;27(2):168-73. doi: 10.1097/ICO.0b013e318159a950.
12 AAV-Mediated Gene Supplementation Therapy in Achromatopsia Type 2: Preclinical Data on Therapeutic Time Window and Long-Term Effects.Front Neurosci. 2017 May 24;11:292. doi: 10.3389/fnins.2017.00292. eCollection 2017.
13 Exome sequencing in developmental eye disease leads to identification of causal variants in GJA8, CRYGC, PAX6 and CYP1B1.Eur J Hum Genet. 2014 Jul;22(7):907-15. doi: 10.1038/ejhg.2013.268. Epub 2013 Nov 27.
14 Autosomal dominant cone-rod dystrophy due to a missense mutation (R838C) in the guanylate cyclase 2D gene (GUCY2D) with preserved rod function in one branch of the family.Ophthalmic Genet. 2000 Dec;21(4):197-209.
15 RPE65 mutation frequency and phenotypic variation according to exome sequencing in a tertiary centre for genetic eye diseases in China.Acta Ophthalmol. 2020 Mar;98(2):e181-e190. doi: 10.1111/aos.14181. Epub 2019 Jul 5.
16 RPGR and RP2: targets for the treatment of X-linked retinitis pigmentosa?.Expert Opin Ther Targets. 2009 Oct;13(10):1239-51. doi: 10.1517/14728220903225016.
17 Examination of SOX2 in variable ocular conditions identifies a recurrent deletion in microphthalmia and lack of mutations in other phenotypes.Mol Vis. 2010 Apr 28;16:768-73.
18 Genetic background-dependent role of Egr1 for eyelid development.Proc Natl Acad Sci U S A. 2017 Aug 22;114(34):E7131-E7139. doi: 10.1073/pnas.1705848114. Epub 2017 Aug 4.
19 The tyrosinase related protein-1 (Tyrp1) promoter in transgenic experiments: targeted expression to the retinal pigment epithelium.Cell Mol Biol (Noisy-le-grand). 1999 Nov;45(7):961-8.
20 Aldo-Keto Reductases: Multifunctional Proteins as Therapeutic Targets in Diabetes and Inflammatory Disease.Adv Exp Med Biol. 2018;1032:173-202. doi: 10.1007/978-3-319-98788-0_13.
21 Apoptosis-inducing signal sequence mutation in carbonic anhydrase IV identified in patients with the RP17 form of retinitis pigmentosa. Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6617-22. doi: 10.1073/pnas.0401529101. Epub 2004 Apr 16.
22 Spectrum of NPHP6/CEP290 mutations in Leber congenital amaurosis and delineation of the associated phenotype.Hum Mutat. 2007 Apr;28(4):416. doi: 10.1002/humu.9485.
23 Genetic Polymorphisms of CFH and ARMS2 Do Not Predict Response to Antioxidants and Zinc in Patients with Age-Related Macular Degeneration: Independent Statistical Evaluations of Data from the Age-Related Eye Disease Study.Ophthalmology. 2018 Mar;125(3):391-397. doi: 10.1016/j.ophtha.2017.09.008. Epub 2017 Oct 9.
24 REP1 inhibits FOXO3-mediated apoptosis to promote cancer cell survival.Cell Death Dis. 2017 Jan 5;8(1):e2536. doi: 10.1038/cddis.2016.462.
25 Differential occurrence of mutations causative of eye diseases in the Chinese population.Hum Mutat. 2002 Mar;19(3):189-208. doi: 10.1002/humu.10053.
26 Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms.Eur J Endocrinol. 2009 Nov;161(5):787-93. doi: 10.1530/EJE-09-0600. Epub 2009 Sep 4.
27 Genomic organization of human DLG4, the gene encoding postsynaptic density 95.J Neurochem. 1999 Dec;73(6):2250-65. doi: 10.1046/j.1471-4159.1999.0732250.x.
28 GRIK5 Genetically Regulated Expression Associated with Eye and Vascular Phenomes: Discovery through Iteration among Biobanks, Electronic Health Records, and Zebrafish.Am J Hum Genet. 2019 Mar 7;104(3):503-519. doi: 10.1016/j.ajhg.2019.01.017. Epub 2019 Feb 28.
29 Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.J Enzyme Inhib Med Chem. 2017 Dec;32(1):1274-1281. doi: 10.1080/14756366.2017.1380638.
30 Novel Homozygous LRP5 Mutations in Mexican Patients with Osteoporosis-Pseudoglioma Syndrome.Genet Test Mol Biomarkers. 2017 Dec;21(12):742-746. doi: 10.1089/gtmb.2017.0118. Epub 2017 Nov 13.
31 A single-base change at a splice acceptor site in the ornithine aminotransferase gene causes abnormal RNA splicing in gyrate atrophy.Hum Genet. 1992 Nov;90(3):305-7. doi: 10.1007/BF00220086.
32 A Two-Week, Randomized, Double-masked Study to Evaluate Safety and Efficacy of Lubricin (150g/mL) Eye Drops Versus Sodium Hyaluronate (HA) 0.18% Eye Drops (Vismed) in Patients with Moderate Dry Eye Disease.Ocul Surf. 2017 Jan;15(1):77-87. doi: 10.1016/j.jtos.2016.08.004. Epub 2016 Sep 8.
33 Association of BTG2, CYR61, ZFP36, and SCD gene polymorphisms with Graves' disease and ophthalmopathy.Thyroid. 2014 Jul;24(7):1156-61. doi: 10.1089/thy.2013.0654. Epub 2014 Jun 3.
34 Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease.ACS Chem Biol. 2017 Mar 17;12(3):825-832. doi: 10.1021/acschembio.6b01048. Epub 2017 Feb 6.
35 A mouse model of a novel missense mutation (Gly83Arg) in a Chinese kindred manifesting vitreous amyloidosis only.Exp Eye Res. 2018 Apr;169:13-19. doi: 10.1016/j.exer.2018.01.017. Epub 2018 Feb 3.
36 Novel ADAM9 homozygous mutation in a consanguineous Egyptian family with severe cone-rod dystrophy and cataract.Br J Ophthalmol. 2014 Dec;98(12):1718-23. doi: 10.1136/bjophthalmol-2014-305231. Epub 2014 Aug 4.
37 [Harmful effects of common drugs on the visual apparatus. Hormones. I. ACTH and glucocorticoids].Bull Soc Belge Ophtalmol. 1972;160(1):274-92.
38 Biochemical defects in 11-cis-retinol dehydrogenase mutants associated with fundus albipunctatus.J Biol Chem. 2001 Dec 28;276(52):49251-7. doi: 10.1074/jbc.M107337200. Epub 2001 Oct 23.
39 Cytochrome P450 Oxidase 2C Inhibition Adds to -3 Long-Chain Polyunsaturated Fatty Acids Protection Against Retinal and Choroidal Neovascularization.Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1919-27. doi: 10.1161/ATVBAHA.116.307558. Epub 2016 Jul 14.
40 Next generation sequencing in a family with autosomal recessive Kahrizi syndrome (OMIM 612713) reveals a homozygous frameshift mutation in SRD5A3.Eur J Hum Genet. 2011 Jan;19(1):115-7. doi: 10.1038/ejhg.2010.132. Epub 2010 Aug 11.
41 pVHL interacts with Ceramide kinase like (CERKL) protein and ubiquitinates it for oxygen dependent proteasomal degradation.Cell Signal. 2015 Nov;27(11):2314-23. doi: 10.1016/j.cellsig.2015.08.011. Epub 2015 Aug 18.
42 Gene therapy into photoreceptors and Mller glial cells restores retinal structure and function in CRB1 retinitis pigmentosa mouse models.Hum Mol Genet. 2015 Jun 1;24(11):3104-18. doi: 10.1093/hmg/ddv062. Epub 2015 Feb 20.
43 Pathogenicity discrimination and genetic test reference for CRX variants based on genotype-phenotype analysis.Exp Eye Res. 2019 Dec;189:107846. doi: 10.1016/j.exer.2019.107846. Epub 2019 Oct 15.
44 A novel GPR143 duplication mutation in a Chinese family with X-linked congenital nystagmus.Mol Vis. 2009;15:810-4. Epub 2009 Apr 22.
45 Coexistence of KCNV2 associated cone dystrophy with supernormal rod electroretinogram and MFRP related oculopathy in a Turkish family.Br J Ophthalmol. 2013 Feb;97(2):169-73. doi: 10.1136/bjophthalmol-2012-302355. Epub 2012 Nov 10.
46 How does a protein's structure spell the difference between health and disease? Our journey to understand glaucoma-associated myocilin.PLoS Biol. 2019 Apr 22;17(4):e3000237. doi: 10.1371/journal.pbio.3000237. eCollection 2019 Apr.
47 A novel missense mutation in the NYX gene associated with high myopia.Ophthalmic Physiol Opt. 2013 May;33(3):346-53. doi: 10.1111/opo.12036. Epub 2013 Feb 14.
48 Generalized progressive retinal atrophy of Sloughi dogs is due to an 8-bp insertion in exon 21 of the PDE6B gene.Cytogenet Cell Genet. 2000;90(3-4):261-7. doi: 10.1159/000056785.
49 Characterisation of microvascular abnormalities using OCT angiography in patients with biallelic variants in USH2A and MYO7A.Br J Ophthalmol. 2020 Apr;104(4):480-486. doi: 10.1136/bjophthalmol-2019-314243. Epub 2019 Jul 2.
50 Two heterozygous mutations identified in one Chinese patient with bilateral macular coloboma.Mol Med Rep. 2017 Sep;16(3):2505-2510. doi: 10.3892/mmr.2017.6887. Epub 2017 Jun 29.
51 ALDH1A3 loss of function causes bilateral anophthalmia/microphthalmia and hypoplasia of the optic nerve and optic chiasm.Hum Mol Genet. 2013 Aug 15;22(16):3250-8. doi: 10.1093/hmg/ddt179. Epub 2013 Apr 15.
52 Calpain-5 Expression in the Retina Localizes to Photoreceptor Synapses.Invest Ophthalmol Vis Sci. 2016 May 1;57(6):2509-21. doi: 10.1167/iovs.15-18680.
53 Mutation screening of the GUCA1B gene in patients with autosomal dominant cone and cone rod dystrophy.Ophthalmic Genet. 2011 Sep;32(3):151-5. doi: 10.3109/13816810.2011.559650. Epub 2011 Mar 15.
54 The ADAMTS18 gene is responsible for autosomal recessive early onset severe retinal dystrophy. Orphanet J Rare Dis. 2013 Jan 28;8:16. doi: 10.1186/1750-1172-8-16.
55 Genome-wide homozygosity mapping in families with leber congenital amaurosis identifies mutations in AIPL1 and RDH12 genes.DNA Cell Biol. 2014 Dec;33(12):876-83. doi: 10.1089/dna.2014.2554.
56 Functional roles of bestrophins in ocular epithelia.Prog Retin Eye Res. 2009 May;28(3):206-26. doi: 10.1016/j.preteyeres.2009.04.004. Epub 2009 May 4.
57 The cardiac calsequestrin gene (CASQ2) is up-regulated in the thyroid in patients with Graves' ophthalmopathy--support for a role of autoimmunity against calsequestrin as the triggering event.Clin Endocrinol (Oxf). 2010 Oct;73(4):522-8. doi: 10.1111/j.1365-2265.2009.03753.x.
58 Isolation and chromosomal localization of two human CDP-diacylglycerol synthase (CDS) genes.Genomics. 1998 Nov 15;54(1):140-4. doi: 10.1006/geno.1998.5547.
59 A novel mutation and variable phenotypic expression in a large consanguineous pedigree with Jalili syndrome.Eye (Lond). 2016 Nov;30(11):1424-1432. doi: 10.1038/eye.2016.137. Epub 2016 Jul 15.
60 CPSF1 mutations are associated with early-onset high myopia and involved in retinal ganglion cell axon projection. Hum Mol Genet. 2019 Jun 15;28(12):1959-1970. doi: 10.1093/hmg/ddz029.
61 The identification and characterization of the p.G91 deletion in CRYBA1 in a Chinese family with congenital cataracts.BMC Med Genet. 2019 Sep 5;20(1):153. doi: 10.1186/s12881-019-0882-z.
62 NAP modulates hyperglycemic-inflammatory event of diabetic retina by counteracting outer blood retinal barrier damage.J Cell Physiol. 2019 Apr;234(4):5230-5240. doi: 10.1002/jcp.27331. Epub 2018 Oct 30.
63 Mapping and genomic characterization of the gene encoding diacylglycerol kinase gamma (DAGK3): assessment of its role in dominant optic atrophy (OPA1).Hum Genet. 1999 Jan;104(1):99-105. doi: 10.1007/s004390050917.
64 (99)Tc(m)-octreotide scintigraphy and serum eye muscle antibodies in evaluation of active thyroid-associated ophthalmopathy.Eye (Lond). 2017 May;31(5):668-676. doi: 10.1038/eye.2017.42. Epub 2017 Apr 7.
65 PARS PLANA VITRECTOMY IN ADVANCED CASES OF VON HIPPEL-LINDAU EYE DISEASE.Retina. 2016 Feb;36(2):325-34. doi: 10.1097/IAE.0000000000000707.
66 Analysis of FOXD3 sequence variation in human ocular disease.Mol Vis. 2012;18:1740-9. Epub 2012 Jun 27.
67 Identification of a new gene mutated in Fraser syndrome and mouse myelencephalic blebs. Nat Genet. 2005 May;37(5):520-5. doi: 10.1038/ng1549. Epub 2005 Apr 17.
68 GNB5 Mutations Cause an Autosomal-Recessive Multisystem Syndrome with Sinus Bradycardia and Cognitive Disability. Am J Hum Genet. 2016 Sep 1;99(3):704-710. doi: 10.1016/j.ajhg.2016.06.025. Epub 2016 Aug 11.
69 Mutations in GRIP1 cause Fraser syndrome. J Med Genet. 2012 May;49(5):303-6. doi: 10.1136/jmedgenet-2011-100590. Epub 2012 Apr 17.
70 Conjunctival Inflammatory Gene Expression Profiling in Dry Eye Disease: Correlations With HLA-DRA and HLA-DRB1.Front Immunol. 2018 Oct 15;9:2271. doi: 10.3389/fimmu.2018.02271. eCollection 2018.
71 Absence of Signal Peptide Peptidase, an Essential Herpes Simplex Virus 1 Glycoprotein K Binding Partner, Reduces Virus Infectivity In Vivo.J Virol. 2019 Nov 13;93(23):e01309-19. doi: 10.1128/JVI.01309-19. Print 2019 Dec 1.
72 Interleukin-28A enhances autoimmune disease in a retinal autoimmunity model.Cytokine. 2014 Dec;70(2):179-84. doi: 10.1016/j.cyto.2014.07.252. Epub 2014 Aug 17.
73 Negative regulation of ciliary length by ciliary male germ cell-associated kinase (Mak) is required for retinal photoreceptor survival. Proc Natl Acad Sci U S A. 2010 Dec 28;107(52):22671-6. doi: 10.1073/pnas.1009437108. Epub 2010 Dec 8.
74 Mutations in MFSD8, encoding a lysosomal membrane protein, are associated with nonsyndromic autosomal recessive macular dystrophy. Ophthalmology. 2015 Jan;122(1):170-9. doi: 10.1016/j.ophtha.2014.07.040. Epub 2014 Sep 13.
75 Aberrant Wnt signalling and cellular over-proliferation in a novel mouse model of Meckel-Gruber syndrome.Dev Biol. 2013 May 1;377(1):55-66. doi: 10.1016/j.ydbio.2013.02.015. Epub 2013 Feb 27.
76 The iridocyclitis of early onset pauciarticular juvenile rheumatoid arthritis: outcome in immunogenetically characterized patients.J Rheumatol. 1992 Jan;19(1):160-3.
77 A case of exudative vitreoretinopathy and chorioretinal coloboma associated with microcephaly in a female with contiguous Xp11.3-11.4 deletion.Ophthalmic Genet. 2018 Jun;39(3):396-398. doi: 10.1080/13816810.2018.1443342. Epub 2018 Apr 4.
78 Bioinformatic approaches for identification and characterization of olfactomedin related genes with a potential role in pathogenesis of ocular disorders.Mol Vis. 2004 Apr 20;10:304-14.
79 Regulation of endocytic trafficking of transferrin receptor by optineurin and its impairment by a glaucoma-associated mutant.BMC Cell Biol. 2010 Jan 19;11:4. doi: 10.1186/1471-2121-11-4.
80 MLGA: a cost-effective approach to the diagnosis of gene deletions in eye development anomalies.Mol Vis. 2009 Jul 28;15:1445-8.
81 From eyeless to neurological diseases.Exp Eye Res. 2017 Mar;156:5-9. doi: 10.1016/j.exer.2015.11.006. Epub 2015 Nov 22.
82 Preliminary evidence for interaction of PTPN12 polymorphism with TSHR genotype and association with Graves' ophthalmopathy.Clin Endocrinol (Oxf). 2007 Nov;67(5):663-7. doi: 10.1111/j.1365-2265.2007.02942.x. Epub 2007 Jul 3.
83 Targeted Multifunctional Lipid ECO Plasmid DNA Nanoparticles as Efficient Non-viral Gene Therapy for Leber's Congenital Amaurosis.Mol Ther Nucleic Acids. 2017 Jun 16;7:42-52. doi: 10.1016/j.omtn.2017.02.005. Epub 2017 Feb 28.
84 The ciliary gene RPGRIP1L is mutated in cerebello-oculo-renal syndrome (Joubert syndrome type B) and Meckel syndrome. Nat Genet. 2007 Jul;39(7):875-81. doi: 10.1038/ng2039. Epub 2007 Jun 10.
85 Identification of novel mutations in the SEMA4A gene associated with retinal degenerative diseases. J Med Genet. 2006 Apr;43(4):378-81. doi: 10.1136/jmg.2005.035055. Epub 2005 Sep 30.
86 Our experience with smartphone and spherical lens for the eye fundus examination during humanitarian project in Africa.Int J Ophthalmol. 2017 Jan 18;10(1):157-160. doi: 10.18240/ijo.2017.01.25. eCollection 2017.
87 Sostdc1 is expressed in all major compartments of developing and adult mammalian eyes.Graefes Arch Clin Exp Ophthalmol. 2019 Nov;257(11):2401-2427. doi: 10.1007/s00417-019-04462-4. Epub 2019 Sep 16.
88 MicroRNA-145 Regulates Pathological Retinal Angiogenesis by Suppression of TMOD3.Mol Ther Nucleic Acids. 2019 Jun 7;16:335-347. doi: 10.1016/j.omtn.2019.03.001. Epub 2019 Mar 21.
89 An examination of the regulatory mechanism of Pxdn mutation-induced eye disorders using microarray analysis.Int J Mol Med. 2016 Jun;37(6):1449-56. doi: 10.3892/ijmm.2016.2572. Epub 2016 Apr 20.
90 Unusual life cycle and impact on microfibril assembly of ADAMTS17, a secreted metalloprotease mutated in genetic eye disease.Sci Rep. 2017 Feb 8;7:41871. doi: 10.1038/srep41871.
91 The embryonic expression patterns and the knockdown phenotypes of zebrafish ADP-ribosylation factor-like 6 interacting protein gene.Dev Dyn. 2009 Jan;238(1):232-40. doi: 10.1002/dvdy.21832.
92 Mutation analysis of B3GALTL in Peters Plus syndrome.Am J Med Genet A. 2008 Oct 15;146A(20):2603-10. doi: 10.1002/ajmg.a.32498.
93 Unusual phenotype in a female patient with a Gly25Ala substitution in the signal peptide region of the COL2A1 gene.Clin Dysmorphol. 2008 Jul;17(3):225-226. doi: 10.1097/MCD.0b013e3282fe1b8e.
94 Familial exudative vitreoretinopathy presentation as persistent fetal vasculature.Am J Ophthalmol Case Rep. 2017 Jun;6:15-17. doi: 10.1016/j.ajoc.2017.01.001. Epub 2017 Feb 2.
95 Identification and functional characterisation of genetic variants in OLFM2 in children with developmental eye disorders.Hum Genet. 2017 Jan;136(1):119-127. doi: 10.1007/s00439-016-1745-8. Epub 2016 Nov 14.
96 Targeted ablation of the Pde6h gene in mice reveals cross-species differences in cone and rod phototransduction protein isoform inventory.J Biol Chem. 2015 Apr 17;290(16):10242-55. doi: 10.1074/jbc.M114.611921. Epub 2015 Mar 4.
97 Microphthalmia, parkinsonism, and enhanced nociception in Pitx3 ( 416insG ) mice.Mamm Genome. 2010 Feb;21(1-2):13-27. doi: 10.1007/s00335-009-9235-0. Epub 2009 Dec 22.
98 Retinol dehydrogenase 12 (RDH12): Role in vision, retinal disease and future perspectives.Exp Eye Res. 2019 Nov;188:107793. doi: 10.1016/j.exer.2019.107793. Epub 2019 Sep 7.
99 Novel association of RP1 gene mutations with autosomal recessive retinitis pigmentosa.J Med Genet. 2005 May;42(5):436-8. doi: 10.1136/jmg.2004.024281.
100 Functional analysis of retinitis pigmentosa 2 (RP2) protein reveals variable pathogenic potential of disease-associated missense variants.PLoS One. 2011;6(6):e21379. doi: 10.1371/journal.pone.0021379. Epub 2011 Jun 27.